Age at elective aortic root surgery in marfan syndrome: does medication matter? a study by the European reference network VASCERN

Back

ESC2025 Premium Access

Age at elective aortic root surgery in marfan syndrome: does medication matter? a study by the European reference network VASCERN

Session: Hereditary connective tissue disorders

Topic: Pharmacotherapy

Speaker: Mr D. Bosshardt (Amsterdam, NL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Mr Daan Bosshardt

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

0 follower

6 more presentations in this session

Vascular involvement in loyes-dietz syndrome: distribution and prevalence of aneurysms and dissections across different vascular territories

Speaker: Doctor L. Dreher (Scottsdale, US)

Exploration of cyclophilin A antibody anti-eCypA as a new approach in the treatment of marfan syndrome

Speaker: Ms H. Witthaus (Kiel, DE)

Health-related quality of life is impaired in marfan syndrome and is strongly associated with lower exercise capacity

Speaker: Doctor G. Teixido Tura (Barcelona, ES)

Evaluation of the impact of a cardiac rehabilitation program on exercise capacity and cardiocirculatory parameters in patients with Marfan syndrome

Speaker: Doctor C. Badia Molins (Badalona, ES)

Evaluation of exercise capacity and cardiovascular parameters through cardiopulmonary exercise testing in patients with Marfan syndrome.

Speaker: Doctor A. Hernandez-Pineda (Barcelona, ES)

Access the full session

Hereditary connective tissue disorders

Speakers: Mr D. Bosshardt, Doctor L. Dreher, Ms H. Witthaus, Doctor G. Teixido Tura, Doctor C. Badia Molins...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources